Literature DB >> 12930288

Aberrant signalling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis.

R C McKenzie1, E Sabin.   

Abstract

Psoriasis is a chronic inflammatory skin disease characterized by the accumulation of red, scaly plaques on the skin. The plaques result from hyperproliferation and incomplete differentiation of keratinocytes (KC) in a process that seems to be driven, in part by skin-infiltrating leucocytes. We believe that the KC have inherent defects in intracellular signalling which could be usefully targeted to allow the development of more effective therapies. We suggest that there are defects in the regulation of the transcription factors: signal transducer and activator of transcription (STAT-1alpha), interferon regulated factor-1 (IRF-1) and NFkappaB which lead to loss of growth and differentiation control when the cells are subjected to physico-chemical and immunological stress. We also highlight recent studies that suggest that peroxisome proliferator-activated receptors, the notch receptor and defects in calcium and other ion transporting proteins may contribute to impairment in the ability of psoriatic KC to differentiate. The role of these systems in the development of the psoriatic phenotype and tests of these hypotheses are proposed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930288     DOI: 10.1034/j.1600-0625.2003.00100.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  8 in total

1.  Calcipotriol affects keratinocyte proliferation by decreasing expression of early growth response-1 and polo-like kinase-2.

Authors:  Jernej Kristl; Petra Slanc; Metka Krasna; Ales Berlec; Matjaz Jeras; Borut Strukelj
Journal:  Pharm Res       Date:  2007-08-02       Impact factor: 4.200

2.  Gene expression profiling of Japanese psoriatic skin reveals an increased activity in molecular stress and immune response signals.

Authors:  Jerzy K Kulski; William Kenworthy; Matthew Bellgard; Ross Taplin; Koichi Okamoto; Akira Oka; Tomotaka Mabuchi; Akira Ozawa; Gen Tamiya; Hidetoshi Inoko
Journal:  J Mol Med (Berl)       Date:  2005-11-11       Impact factor: 4.599

3.  SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis.

Authors:  Kriangsak Ruchusatsawat; Jongkonnee Wongpiyabovorn; Shanop Shuangshoti; Nattiya Hirankarn; Apiwat Mutirangura
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

Review 4.  The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis.

Authors:  Athanasios Mavropoulos; Eirini I Rigopoulou; Christos Liaskos; Dimitrios P Bogdanos; Lazaros I Sakkas
Journal:  Clin Dev Immunol       Date:  2013-09-12

5.  Psoriasis drug development and GWAS interpretation through in silico analysis of transcription factor binding sites.

Authors:  William R Swindell; Mrinal K Sarkar; Philip E Stuart; John J Voorhees; James T Elder; Andrew Johnston; Johann E Gudjonsson
Journal:  Clin Transl Med       Date:  2015-03-19

6.  Psoriasiform skin disease in transgenic pigs with high-copy ectopic expression of human integrins α2 and β1.

Authors:  Nicklas Heine Staunstrup; Karin Stenderup; Sidsel Mortensen; Maria Nascimento Primo; Cecilia Rosada; Torben Steiniche; Ying Liu; Rong Li; Mette Schmidt; Stig Purup; Frederik Dagnæs-Hansen; Lisbeth Dahl Schrøder; Lars Svensson; Thomas Kongstad Petersen; Henrik Callesen; Lars Bolund; Jacob Giehm Mikkelsen
Journal:  Dis Model Mech       Date:  2017-07-01       Impact factor: 5.758

7.  Psoriasis-Associated Inflammatory Conditions Induce IL-23 mRNA Expression in Normal Human Epidermal Keratinocytes.

Authors:  Evelyn Kelemen; Éva Ádám; Stella Márta Sági; Anikó Göblös; Lajos Kemény; Zsuzsanna Bata-Csörgő; Márta Széll; Judit Danis
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

8.  Loss of epidermal Evi/Wls results in a phenotype resembling psoriasiform dermatitis.

Authors:  Iris Augustin; Julia Gross; Daniel Baumann; Claudia Korn; Grainne Kerr; Tamara Grigoryan; Cornelia Mauch; Walter Birchmeier; Michael Boutros
Journal:  J Exp Med       Date:  2013-08-05       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.